3. Summary of Significant Accounting Policies (Details 8) (USD $)
|
0 Months Ended |
1 Months Ended |
|
Sep. 03, 2014
|
Sep. 26, 2014
|
Sep. 10, 2014
|
Aug. 28, 2014
|
Jun. 04, 2014
|
Dec. 23, 2013
|
Dec. 04, 2013
|
Jun. 26, 2013
|
Apr. 11, 2013
|
Dec. 31, 2014
|
Jul. 07, 2014
|
Feb. 10, 2014
|
Jun. 30, 2014
|
Jun. 23, 2014
|
Sep. 30, 2014
|
Expected life (in months) |
36 months
|
12 months
|
12 months
|
6 months
|
8 months
|
36 months
|
24 months
|
12 months
|
12 months
|
|
|
|
|
|
|
Expected volatility |
153.80%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
|
116.60%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
|
117.60%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
|
104.40%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
|
121.80%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
|
151.40%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
|
170.30%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
|
189.20%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
|
206.20%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1
|
|
|
|
|
|
|
Risk-free interest rate |
0.99%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
|
0.11%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
|
0.12%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
|
0.05%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
|
0.07%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
|
0.77%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
|
0.30%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
|
0.13%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
|
0.10%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1
|
|
|
|
|
|
|
Exercise price |
$ 0.35pbio_ExercisePriceWarrants
|
$ 0.16pbio_ExercisePriceWarrants
|
$ 0.13pbio_ExercisePriceWarrants
|
$ 0.14pbio_ExercisePriceWarrants
|
$ 0.45pbio_ExercisePriceWarrants
|
$ 0.40pbio_ExercisePriceWarrants
|
$ 0.40pbio_ExercisePriceWarrants
|
$ 0.17pbio_ExercisePriceWarrants
|
$ 0.14pbio_ExercisePriceWarrants
|
|
|
|
|
|
|
Fair value per warrant |
$ 0.24pbio_FairValuePerWarrant1
|
$ 0.19pbio_FairValuePerWarrant1
|
$ 0.12pbio_FairValuePerWarrant1
|
$ 0.15pbio_FairValuePerWarrant1
|
$ 0.16pbio_FairValuePerWarrant1
|
$ 0.17pbio_FairValuePerWarrant1
|
$ 0.16pbio_FairValuePerWarrant1
|
$ 0.25pbio_FairValuePerWarrant1
|
$ 0.29pbio_FairValuePerWarrant1
|
|
|
|
|
|
|
Transaction 1 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
6 months
|
12 months
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
111.47%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
117.90%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
0.12%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
0.12%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
$ 0.16pbio_ExercisePriceWarrants / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
$ 0.21pbio_ExercisePriceWarrants / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
$ 0.11pbio_FairValuePerWarrant1 / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
$ 0.18pbio_FairValuePerWarrant1 / us-gaap_StatementScenarioAxis = pbio_TransactionOneMember
|
|
|
|
|
Transaction 2 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
6 months
|
12 months
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
111.47%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
117.90%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
0.12%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
0.12%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
$ 0.17pbio_ExercisePriceWarrants / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
$ 0.21pbio_ExercisePriceWarrants / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
$ 0.11pbio_FairValuePerWarrant1 / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
$ 0.18pbio_FairValuePerWarrant1 / us-gaap_StatementScenarioAxis = pbio_TransactionTwoMember
|
|
|
|
|
Conversion options revalued Three [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
|
|
2 months
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
116.40%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedThreeMember
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
0.04%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedThreeMember
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
$ 0.25pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedThreeMember
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
|
|
$ 0.2pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedThreeMember
|
|
|
|
Conversion options revalued Four [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
|
|
5 months
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
137.90%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFourMember
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
0.07%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFourMember
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
$ 0.25pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFourMember
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
|
|
$ 0.23pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedFourMember
|
|
|
|
Conversion options revalued one [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
|
|
|
1 month
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
77.10%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0.02%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.40pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.02pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedOneMember
|
Conversion options revalued Two [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
|
|
|
|
30 months
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
|
|
|
|
159.20%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedTwoMember
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
|
0.73%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedTwoMember
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.40pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedTwoMember
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.32pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedTwoMember
|
|
Conversion options revalued Six [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
1 month
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
77.40%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedSixMember
|
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
0.03%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedSixMember
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
$ 0.45pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedSixMember
|
|
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion options revalued Eight [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
2 months
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
121.70%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedEightMember
|
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
0.04%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedEightMember
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
$ 0.15pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedEightMember
|
|
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
$ 0.11pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedEightMember
|
|
|
|
|
|
Conversion options revalued Nine [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
32 months
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
154.10%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedNineMember
|
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
0.88%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedNineMember
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
$ 0.35pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedNineMember
|
|
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
$ 0.19pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedNineMember
|
|
|
|
|
|
Conversion options revalued Ten [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
8 months
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
106.60%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedTenMember
|
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
0.18%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedTenMember
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
$ 0.14pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedTenMember
|
|
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
$ 0.14pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedTenMember
|
|
|
|
|
|
Conversion options revalued Eleven [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expected life (in months) |
|
|
|
|
|
|
|
|
|
9 months
|
|
|
|
|
|
Expected volatility |
|
|
|
|
|
|
|
|
|
106.20%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedElevenMember
|
|
|
|
|
|
Risk-free interest rate |
|
|
|
|
|
|
|
|
|
0.17%pbio_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedElevenMember
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
$ 0.15pbio_ExercisePriceWarrants / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedElevenMember
|
|
|
|
|
|
Fair value per warrant |
|
|
|
|
|
|
|
|
|
$ 0.13pbio_FairValuePerWarrant1 / us-gaap_ConversionOfStockByUniqueDescriptionAxis = pbio_ConversionOptionsRevaluedElevenMember
|
|
|
|
|
|